1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
THC Biomed Intl Ltd.

THC Biomed Intl Ltd.

THC.CN
THC Biomed Intl Ltd.CA flagCanadian Securities Exchange
0.02
CAD
- -
- -
3.28MMarket Cap
THC Biomed Intl Ltd.
THC.CN
(Canadian Securities Exchange)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
0.03
0.02
0.02
0.02
Revenue per Share
-0.15
-0.08
-0.43
-0.07
-0.19
-0.05
- -
-0.08
-0.08
-0.01
-0.01
-0.11
-0.1
- -
-0.04
-0.02
-0.02
Basic EPS, GAAP
-0.11
-0.04
-0.05
-0.1
-0.01
-0.06
-0.01
-0.04
-0.02
-0.01
-0.03
-0.07
-0.07
-0.01
-0.01
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.82
-1.7
-1.67
-0.53
-0.59
-3.09
-0.01
-1.38
-0.08
- -
0.01
0.03
0.01
0.02
0.01
0.04
0.03
Book Value per Share
0.68
0.54
0.04
0.24
-0.01
-0.07
- -
- -
-0.04
- -
0.02
0.11
0.1
0.1
0.06
0.04
0.03
Tangible Book Value per Share
6
6
9
32
43
7
48
17
41
89
102
112
133
156
164
164
164
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
4
4
3
3
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2,425.05
-260.49
-318.44
4.91
-157.25
-95.89
-106.7
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
Depreciation Expense
-1
-1
-4
-2
-8
- -
- -
-1
-3
-1
-1
-12
-13
- -
-6
-3
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,010.2
-1,346.42
-852.53
-3.87
-168.49
-91.79
-128.44
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
-2
- -
-4
7
2
2
-2
-3
-5
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
1
1
1
2
1
1
LT Debt
4
4
- -
8
- -
- -
- -
- -
-2
- -
2
12
13
15
10
7
5
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-119.74
-593.12
-506.45
-5.83
-262.78
-82.68
-177.94
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Oct'23
Jan'23
Apr'23
ST Debt
4
4
4
LT Borrowings
- -
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
169
169
169
Market Capitalization
5
5
7

Working Capital

FRC

•

in mil. unless spec.
Oct'23
Jan'23
Apr'23
Total Current Assets
4
4
3
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
3
3
3
Total Current Liabilities
7
8
8
Payables & Accruals
3
4
4
ST Debt
4
4
4
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
334.81%
94.89%
-29.13%
Free Cash Flow
47.3%
27.95%
43.76%
Net Income, GAAP
617.92%
1,129.32%
-51.79%
Sales/Revenue/Turnover
- -
333.14%
-11.51%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
1
1
1
1
4
2022
1
1
1
1
3
2023
1
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
-0.02
-0.01
- -
-0.04
2022
- -
-0.01
- -
- -
-0.02
2023
- -
-0.01
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
AB Science S.A. (ABSCF)
MJ Holdings, Inc. (MJNE)
Delta 9 Cannabis Inc. (DLTNF)
Avant Brands Inc. (AVTBF)
Towa Pharmaceutical Co., Ltd. (4553.T)
Toho Holdings Co., Ltd. (8129.T)
Business
THC Biomed Intl Ltd. is a Canada-based licensed producer of medical and recreational cannabis, focused on the cultivation, processing, and sale of high-quality indoor-grown cannabis products through its subsidiary THC BioMed Ltd. The company offers dried flower in sativa, hybrid, and indica strains such as Dragon's Lettuce and Nebula; glass pre-rolls; ICE bubble hash one-hitters; cannabis beverage shots, gummies, and biscuits under the THC KISS brand; pure cannabis sticks; extracts including resin and oil; edible concentrates; and topical products, along with cannabis genetics, clones, and related biological assets like mother plants for propagation. It operates in the alternative medicine and pharmaceuticals sector, primarily serving the Canadian market with sales concentrated domestically, and maintains a single reportable segment in scientific research, development, cultivation, and cannabis sales; subsidiaries include Clone Shipper Ltd., which holds rights to live plant transportation products, THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd., and THC BioMed Lesotho Ltd. Founded in 2012 and headquartered at 1340 St. Paul Street in Kelowna, British Columbia, the company employs approximately 35 people and holds Health Canada licenses for small-batch production. Recent developments include a Health Canada license renewal to August 2026 announced in August 2025, an agreement to export cannabis to a major German distributor in August 2025, and the sale of a strata unit in Kelowna, B.C., for CAD 0.55 million completed in 2024.